Cynthia Anderson

No open positions remaining

Net worth: 8 065 $ as of 2026-05-30

57 year

Health Technology

Consumer Services

Profile

Cynthia L.
Anderson formerly worked at Alnylam Pharmaceuticals, Inc., as Chief Accounting Officer from 2019 to 2023 and Vistagen Therapeutics, Inc., as Chief Financial Officer from 2023 to 2025.
Ms. Anderson received her undergraduate degree from the University of Connecticut and graduate degree from The University of Texas at Dallas.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VISTAGEN THERAPEUTICS, INC. 0.03%	2025-07-15	12,801 ( 0.03% )	8 065 $	2026-05-30

Former positions of Cynthia Anderson

Companies	Position	End
VISTAGEN THERAPEUTICS, INC.	Director of Finance/CFO	2025-09-14
ALNYLAM PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	2022-12-31

See the detail of Cynthia Anderson's experience

Training of Cynthia Anderson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cynthia Anderson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference	Health Technology
University of Connecticut University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Texas at Dallas The University of Texas at Dallas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies	Health Technology